Drug Pipeline

Cabotegravir - Injectable Suspension (CAB LA) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06158126 UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study Pre-exposure Prophylaxis Recruiting
Phase 3
NCT02951052 Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting… Infection, Human Immunodeficiency Virus Active, Not Recruiting
NCT02938520 Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular… HIV Infections Active, Not Recruiting
Not specified
NCT07516548 Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV HIV Infections Not Yet Recruiting
Sponsors Running Cabotegravir - Injectable Suspension (CAB LA) Trials
ViiV Healthcare (2) University of North Carolina, Chapel Hill (1) University of Alabama at Birmingham (1)
Get alerts when Cabotegravir - Injectable Suspension (CAB LA) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free